A lung cancer that changes its identity may be hiding in plain sight
Peer-Reviewed Publication
Updates every hour. Last Updated: 25-May-2026 22:16 ET (26-May-2026 02:16 GMT/UTC)
Researchers from the Institute for Systems Biology (ISB) and collaborators show that some lung cancers can change identity as they evolve, forming hybrid cell states and immune-protected regions that may help tumors evade treatment. The findings point to new opportunities for earlier detection and more precise therapies.
Today, @AmerGeriatrics names Linda Ferrie as the first ever recipient of the AGS/ADGAP Outstanding Geriatric Medicine Education Coordinator of the Year Award #AGS26 https://bit.ly/4c1MWFE
The well-being of a supervisor is reflected through supervisor-subordinate relationships in employee motivation and performance, and consequently, in the company’s competitiveness. In his doctoral research at the University of Vaasa, Finland, Project Researcher Jussi Tanskanen demonstrates that an exhausted leader lacks the resources to maintain high-quality relationships with subordinates, leading to a collapse in employee dedication. This phenomenon is particularly pronounced in today’s intensive work environment and remote work settings.
Europe’s dependence on fossil fuels is not only making the continent economically and politically vulnerable, it also has dramatic consequences for the population’s health. Growing air pollution, heat damage and the climate-related spread of infectious diseases are looming, warns the 2026 Europe Report of the Lancet Countdown on Health and Climate Change, which its co-directors Prof. Dr Joacim Rocklöv (Heidelberg University) and Prof. Dr Cathryn Tonne (Barcelona Institute for Global Health) are about to present to the public. Together with other experts from academia, practice and policy they will discuss the report’s results during a public event at Heidelberg University, comparing the current findings with successful measures for climate action and health protection. The launch event with livestreaming is to take place on 22 April 2026.
A research team led by Sir Run-Run Shaw Hospital, Zhejiang University School of Medicine, has published a comprehensive review in ExRNA that sorts out the diverse roles of extracellular vesicle-associated RNAs (EV-RNAs) in the development and progression of inflammatory bowel disease (IBD). By integrating the latest findings from multi-omics studies and animal experiments, the review points out that EV-RNAs can serve as non-invasive biomarkers for early IBD detection and disease monitoring, and also hold great potential as targets for next-generation targeted therapies. This work provides a solid theoretical basis for advancing personalized precision treatment for the millions of IBD patients worldwide suffering from this chronic recurrent gastrointestinal disorder.
The next major advance in medical AI may lie not in analyzing more data, but in understanding how health data change over time. A recent editorial in Intelligent Medicine argues that dynamics-driven approaches, designed to detect change rather than merely classify state, can identify the critical moment when a patient's biological system is approaching a disease tipping point — with single-sample analysis reaching AUC > 0.9 and hybrid deep learning cutting blood-glucose prediction error by more than 55%, enabling earlier and more individualized intervention.